This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The award has a ceiling value of $16,175.68 and a period of performance through December 30, 2024. The contract is a firm-fixed-price delivery order, meaning the price is set and the vendor is responsible for delivering the specified products. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/30/25, 12:53 AM